San Diego—Patients given opioids for ankylosing spondylitis (AS) may be getting a treatment that offers no real benefits and missing out on anti-inflammatory drugs that have considerable evidence for efficacy, a new study suggests.
Indeed, almost half of AS patients in the study were prescribed an opioid, despite no evidence that the drugs mitigate the inflammatory condition, the researchers reported during the 2017 American College of Rheumatology (ACR)/ARHP annual meeting (abstract